![]() ![]() Our goal is to help healthcare providers diagnose, treat and send patients on their way in the quickest and most efficient way possible. Knowing how that feels, we want patients to be treated faster and more accurately, so they can return home and continue living their best and healthiest lives. At some point or another, a family member, a loved one or even we have been in the hospital. Narendra Soman: When our team thinks about our customers, we often imagine ourselves or our families. That’s how we began developing i-STAT Alinity. Our team knew there was more we could do to make often scary healthcare moments – from a potential heart attack to the need for dialysis – a little better. We also want to do all we can to help the healthcare providers who treat these patients. ![]() It’s about helping families and helping those who arrive at a hospital and need rapid treatment decisions. However, we knew we could do more to push the boundaries and develop an even better with-patient device that could make a difference in the healthcare industry.įor me and for many people on our R&D team, the inspiration for our work is the patient. Matt Bates: At Abbott, we’re very proud of our existing i-STAT device and the expertise we have in the point of care (testing that takes place with-patient) industry. What prompted or inspired your R&D team to develop i-STAT Alinity? The Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) research team were the first to demonstrate how this TBI blood test can be used for the benefit of TBI patients in clinical care.Abbott's R&D expert, Narendra Soman, Ph.D., shares his thoughts for how i-STAT Alinity, a new handheld blood testing tool, could help patients get healthier, faster. Army Medical Materiel Development Activity (USAMMDA), played a critical role in developing the test run on Abbott’s i-STAT TBI platform. Army Medical Research and Development Command’s (USAMRDC) U.S. Department of Defense (DoD) – which has been dedicated to developing a solution for the objective detection and evaluation of TBI for more than a decade. The TBI blood test was developed in collaboration with the U.S. Our vision for the future is that we’d have a 15-minute, portable test that can be used outside the traditional healthcare setting where people experience head injuries and need a quick evaluation, like sporting events. We are also working on a whole blood test, which would eliminate the need for separation of plasma and could be used at the patient’s side in a healthcare setting. Rapid diagnostic devices like i-STAT TBI allow healthcare workers to triage patients with traumatic brain injuries faster. When hospital stay time is of the essence, having a TBI blood test available could help eliminate wait time in the emergency room and could reduce the number of unnecessary CT scans by up to 40%. And even though concussions from sporting events are on the decline, slips and falls are still occurring, which means there is still a need for concussion diagnosis and treatment. Especially as hospitals near or are at capacity. Time is of the essence during the pandemicĪvoiding the hospital altogether, or getting in and out as quickly as possible, is top of mind for most people during the COVID-19 era. For those who test positive, this test result complements CT scans to help clinicians evaluate whether someone has a TBI. A negative result on this test can be used to rule out the need for a head CT scan, a common tool used to evaluate concussion. This test measures specific proteins present in the blood after a TBI. TBIs, including concussions, refer to an alteration in brain function, caused by an external force. Tests results are available within 15 minutes after plasma is placed in the test cartridge. Our i-STAT TBI plasma test is the first rapid handheld traumatic brain injury (TBI) blood test, which will help clinicians assess individuals with suspected mild TBIs, including concussions. The first rapid handheld objective blood test for concussions For a condition that impacts millions annually and poses short-term risk, long-term risk, and even death-objective testing used in tandem with these methods is crucial. Previously, concussions and TBIs have been evaluated through methods such as CT scan, patient questionnaire, or a neurological exam, which, in some cases, are not empirical on their own. ![]() The main hurdle to recovery is that these injuries are often undiagnosed or misdiagnosed. However, there has never been an objective method of assessing patients suspected to have sustained these invisible injuries-until now. An estimated 4.8 million emergency room visits per year can be attributed to TBIs, and roughly 40% of all concussions are caused by slips and falls. Traumatic brain injuries (TBI), including concussions, are common, and not only within the sports world. ![]()
0 Comments
Leave a Reply. |